Journal Mobile Options
Table of Contents
Vol. 23, No. 6, 1991
Issue release date: 1991
Add to my selection Citation Download
Ophthalmic Res 1991;23:303–308
(DOI:10.1159/000267127)
Paper

Influence of Iodide on Cataractogenesis in Emory Mice

Buchberger W.a · Winkler R.b · Moser M.b · Rieger G.c
Departments of aChemistry, bPhysiology, and cOphthalmology, Paracelsus Institute, Bad Hall, Austria Ophthalmic Res 1991;23:303–308 (DOI:10.1159/000267127)

Abstract

Cataract development was studied in two groups of Emory mice by periodical biomicroscopic examinations (beginning at 5 weeks of age) and by a final evaluation of water-soluble SH groups in the lenses. The experimental group was given 256 μg iodide/kg body weight with the drinking water throughout the study. The untreated control group received tap water. Iodide treatment induced a delay of cataract formation, resulting in a significant reduction of the time to progress from cataract degree 1 to degree 2 (iodide-treated group 12.8 ± 1.7 weeks, untreated group 9.9 ± 1.0 weeks; p < 0.025). A still significant difference in the degree of cataract was also found between the two groups at week 47 of age. No difference was found in the content of water-soluble SH groups. The results are discussed in relation to the known antioxidant and OH-scavenging effect of iodide and to the oxidative changes in the lens occurring during progression of cataract development.

 goto top of outline Author Contacts

Dr. G. Rieger, Augenabteilung des Paracelsus-Instituts, A-4540 Bad Hall (Austria)


 goto top of outline Article Information

Received: October 11, 1990
Accepted: June 7, 1991
Published online: December 10, 2009
Number of Print Pages : 6


 goto top of outline Publication Details

Ophthalmic Research (Journal for Research in Experimental and Clinical Ophthalmology)

Vol. 23, No. 6, Year 1991 (Cover Date: 1991)

Journal Editor: Pleyer U. (Berlin)
ISSN: 0030-3747 (Print), eISSN: 1423-0259 (Online)

For additional information: http://www.karger.com/ORE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.